The results have demonstrated that daily administration of CTS ameliorates both emotional and cognitive deficits of SAMP8 with and without ischemic insult and suggested that the effect on the deficits is attributable to the recovery of neuroplasticity-related neuronal signaling and the VEGF/PDGF signaling systems deteriorated by aging. This evidence concerns the gene VEGFA and Cognitive impairment.